Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck

This study aimed to investigate the 2-year long-term outcomes and prognostic factors associated with the response to nivolumab.

Source: Auris, Nasus, Larynx - February 26, 2022 Category: ENT & OMF Authors: Shuya Otsuki, Ryusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, Hisanobu Tamaki, Ryo Asato, Morimasa Kitamura, Kazuyuki Ichimaru, Yoshiharu Kitani, Yohei Kumabe, Keigo Honda, Takashi Tsujimura, Hiroyuki Harada, Koji Ushiro, Koichi Omori Tags: Original Article Source Type: research